These findings indicate that, rather disappointingly, the additional measurement of anti-GPIb antibody-producing B cells on top of the anti-GPIIb/IIIa ELISPOT assay does not improve the diagnostic accuracy for patients suspected of having ITP. This evidence concerns the gene ITGA2B and autoimmune thrombocytopenic purpura.